Bone Harvester Market By Type (Marrow Harvesting, Cancellous Bone Harvesting) , By Application (Fractures, Fusions, Bone Repair, Others) By End User (Hospitals, Ambulatory Surgery Centers, Diagnostic Centers) : Global Opportunity Analysis and Industry Forecast, 2024-2033
The bone harvester market was valued at $13.5 million in 2023, and is projected t%li%reach $23.4 million by 2033, growing at a CAGR of 5.7% from 2024 t%li%2033.
A bone harvester is a medical device equipped with a handle and a hollow tube with sharp cutting edges, which are used for efficient removal of bone graft. This system enables bone graft removal through a small skin incision, minimizing patient’s discomfort. A bone graft is required t%li%replace damaged bones caused due t%li%a range of orthopedic aberrations such as non-unions, delayed unions, comminuted fractures, bone disorders, and congenital diseases.
The growth of the global bone harvester market is majorly driven by surge in demand for minimally invasive procedures, alarming increase in prevalence of orthopedic diseases, and rise in cases of accidents. According t%li%an article published by Wolters Kluwer, a Dutch information services company, almost tw%li%million bone grafting procedures are performed worldwide per year. Among these, 500,000 bone graft are performed annually in the U.S. alone. Moreover, rise in geriatric population significantly contributes toward the market growth. Aged individuals are highly susceptible t%li%bone-related disorders such as osteoporosis and arthritis. This is attributed t%li%the fact that minerals in bones of aged individuals start t%li%leech out, making them brittle, fragile, and easily breakable, thereby necessitating the need for bone harvesters. As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated t%li%increase t%li%1.4 billion by 2030 and 2.1 billion by 2050. However, high cost associated with bone harvesters acts as the key deterrent factor of the global market. On the contrary, heavy investments by key players in R&D t%li%enhance the efficacy and safety of bone harvesters are expected t%li%offer remunerative opportunities for the expansion of the global market during the forecast period. Moreover, new product developments and innovations are aimed at addressing unmet clinical needs, improving the quality of bone grafts and reducing healthcare costs, which are expected t%li%open new avenues for the market growth.
The global bone harvester market is segmented int%li%type, application, end user, and region. On the basis of type, the market is divided int%li%marrow harvesting and cancellous bone harvesting. Depending on application, it is segregated int%li%fractures, fusions, bone repair, and others. As per end user, it is fragmented int%li%hospitals, ambulatory surgery centers, and diagnostic centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By type, the marrow harvesting segment dominated the market share in 2023.
On the basis of end user, the hospitals segment was the major shareholder, and is expected t%li%continue the same trend in the coming years.
Region wise, Asia-Pacific is anticipated t%li%govern the leading position by 2033.
Competition Analysis
Competitive analysis and profiles of the major players in the global bone harvester market include Acumed, LLC, Globus Medical Inc, Arthrex GmbH, Johnson and Johnson (DePuy Synthes), Paradigm BioDevices, Inc, Biogennix, LLC, Spierings Orthopaedics B.V., Zimmer Biomet Holding, Inc., Avitus Orthopaedics, Inc., and Titan Instruments. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships t%li%sustain the intense competition and capture maximum market share.
Additional benefits you will get with this purchase are:
By Type
A bone harvester is a medical device equipped with a handle and a hollow tube with sharp cutting edges, which are used for efficient removal of bone graft. This system enables bone graft removal through a small skin incision, minimizing patient’s discomfort. A bone graft is required t%li%replace damaged bones caused due t%li%a range of orthopedic aberrations such as non-unions, delayed unions, comminuted fractures, bone disorders, and congenital diseases.
The growth of the global bone harvester market is majorly driven by surge in demand for minimally invasive procedures, alarming increase in prevalence of orthopedic diseases, and rise in cases of accidents. According t%li%an article published by Wolters Kluwer, a Dutch information services company, almost tw%li%million bone grafting procedures are performed worldwide per year. Among these, 500,000 bone graft are performed annually in the U.S. alone. Moreover, rise in geriatric population significantly contributes toward the market growth. Aged individuals are highly susceptible t%li%bone-related disorders such as osteoporosis and arthritis. This is attributed t%li%the fact that minerals in bones of aged individuals start t%li%leech out, making them brittle, fragile, and easily breakable, thereby necessitating the need for bone harvesters. As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated t%li%increase t%li%1.4 billion by 2030 and 2.1 billion by 2050. However, high cost associated with bone harvesters acts as the key deterrent factor of the global market. On the contrary, heavy investments by key players in R&D t%li%enhance the efficacy and safety of bone harvesters are expected t%li%offer remunerative opportunities for the expansion of the global market during the forecast period. Moreover, new product developments and innovations are aimed at addressing unmet clinical needs, improving the quality of bone grafts and reducing healthcare costs, which are expected t%li%open new avenues for the market growth.
The global bone harvester market is segmented int%li%type, application, end user, and region. On the basis of type, the market is divided int%li%marrow harvesting and cancellous bone harvesting. Depending on application, it is segregated int%li%fractures, fusions, bone repair, and others. As per end user, it is fragmented int%li%hospitals, ambulatory surgery centers, and diagnostic centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By type, the marrow harvesting segment dominated the market share in 2023.
On the basis of end user, the hospitals segment was the major shareholder, and is expected t%li%continue the same trend in the coming years.
Region wise, Asia-Pacific is anticipated t%li%govern the leading position by 2033.
Competition Analysis
Competitive analysis and profiles of the major players in the global bone harvester market include Acumed, LLC, Globus Medical Inc, Arthrex GmbH, Johnson and Johnson (DePuy Synthes), Paradigm BioDevices, Inc, Biogennix, LLC, Spierings Orthopaedics B.V., Zimmer Biomet Holding, Inc., Avitus Orthopaedics, Inc., and Titan Instruments. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships t%li%sustain the intense competition and capture maximum market share.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting t%li%16 analyst hours t%li%solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent t%li%3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
- Regulatory Guidelines
- Additional company profiles with specific t%li%client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
By Type
- Marrow Harvesting
- Cancellous Bone Harvesting
- Fractures
- Fusions
- Bone Repair
- Others
- Hospitals
- Ambulatory Surgery Centers
- Diagnostic Centers
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Acumed, LLC
- Globus Medical Inc
- Arthrex GmbH
- Johnson and Johnson (DePuy Synthes)
- Paradigm BioDevices, Inc
- Biogennix, LLC
- Spierings Orthopaedics B.V.
- Zimmer Biomet Holding, Inc.
- Avitus Orthopaedics, Inc
- Titan Instruments
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.5. Market Dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4: GLUCOSE MONITORING DEVICES MARKET, BY DEVICE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Device
4.2. Blood Glucose Meters
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Continuous Glucose Monitoring Systems
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Flash Glucose Monitoring Systems
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.5. Smartphone Apps And Wearables
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
CHAPTER 5: GLUCOSE MONITORING DEVICES MARKET, BY PATIENT TYPE
5.1. Market Overview
5.1.1 Market Size and Forecast, By Patient Type
5.2. Type 1 Diabetes
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Type 2 Diabetes
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
CHAPTER 6: GLUCOSE MONITORING DEVICES MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Hospitals And Clinics
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Home Care Settings
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Others
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
CHAPTER 7: GLUCOSE MONITORING DEVICES MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Device
7.2.3. Market Size and Forecast, By Patient Type
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Glucose Monitoring Devices Market
7.2.6.1. Market Size and Forecast, By Device
7.2.6.2. Market Size and Forecast, By Patient Type
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Glucose Monitoring Devices Market
7.2.7.1. Market Size and Forecast, By Device
7.2.7.2. Market Size and Forecast, By Patient Type
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Glucose Monitoring Devices Market
7.2.8.1. Market Size and Forecast, By Device
7.2.8.2. Market Size and Forecast, By Patient Type
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Device
7.3.3. Market Size and Forecast, By Patient Type
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. France Glucose Monitoring Devices Market
7.3.6.1. Market Size and Forecast, By Device
7.3.6.2. Market Size and Forecast, By Patient Type
7.3.6.3. Market Size and Forecast, By End User
7.3.7. Germany Glucose Monitoring Devices Market
7.3.7.1. Market Size and Forecast, By Device
7.3.7.2. Market Size and Forecast, By Patient Type
7.3.7.3. Market Size and Forecast, By End User
7.3.8. Italy Glucose Monitoring Devices Market
7.3.8.1. Market Size and Forecast, By Device
7.3.8.2. Market Size and Forecast, By Patient Type
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Spain Glucose Monitoring Devices Market
7.3.9.1. Market Size and Forecast, By Device
7.3.9.2. Market Size and Forecast, By Patient Type
7.3.9.3. Market Size and Forecast, By End User
7.3.10. UK Glucose Monitoring Devices Market
7.3.10.1. Market Size and Forecast, By Device
7.3.10.2. Market Size and Forecast, By Patient Type
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest of Europe Glucose Monitoring Devices Market
7.3.11.1. Market Size and Forecast, By Device
7.3.11.2. Market Size and Forecast, By Patient Type
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Device
7.4.3. Market Size and Forecast, By Patient Type
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. China Glucose Monitoring Devices Market
7.4.6.1. Market Size and Forecast, By Device
7.4.6.2. Market Size and Forecast, By Patient Type
7.4.6.3. Market Size and Forecast, By End User
7.4.7. Japan Glucose Monitoring Devices Market
7.4.7.1. Market Size and Forecast, By Device
7.4.7.2. Market Size and Forecast, By Patient Type
7.4.7.3. Market Size and Forecast, By End User
7.4.8. India Glucose Monitoring Devices Market
7.4.8.1. Market Size and Forecast, By Device
7.4.8.2. Market Size and Forecast, By Patient Type
7.4.8.3. Market Size and Forecast, By End User
7.4.9. South Korea Glucose Monitoring Devices Market
7.4.9.1. Market Size and Forecast, By Device
7.4.9.2. Market Size and Forecast, By Patient Type
7.4.9.3. Market Size and Forecast, By End User
7.4.10. Australia Glucose Monitoring Devices Market
7.4.10.1. Market Size and Forecast, By Device
7.4.10.2. Market Size and Forecast, By Patient Type
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Glucose Monitoring Devices Market
7.4.11.1. Market Size and Forecast, By Device
7.4.11.2. Market Size and Forecast, By Patient Type
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Device
7.5.3. Market Size and Forecast, By Patient Type
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Glucose Monitoring Devices Market
7.5.6.1. Market Size and Forecast, By Device
7.5.6.2. Market Size and Forecast, By Patient Type
7.5.6.3. Market Size and Forecast, By End User
7.5.7. South Africa Glucose Monitoring Devices Market
7.5.7.1. Market Size and Forecast, By Device
7.5.7.2. Market Size and Forecast, By Patient Type
7.5.7.3. Market Size and Forecast, By End User
7.5.8. Saudi Arabia Glucose Monitoring Devices Market
7.5.8.1. Market Size and Forecast, By Device
7.5.8.2. Market Size and Forecast, By Patient Type
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Glucose Monitoring Devices Market
7.5.9.1. Market Size and Forecast, By Device
7.5.9.2. Market Size and Forecast, By Patient Type
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Menarini Diagnostics S.R.L.
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Senseonics, A.
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Novo Nordisk A/S
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. GlySens Incorporated
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Johnson And Johnson
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. DexCom, Inc.
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Medtronic Plc
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. F. Hoffman-La Roche Ltd
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Abbott Laboratories
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. B. Braun SE
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.5. Market Dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4: GLUCOSE MONITORING DEVICES MARKET, BY DEVICE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Device
4.2. Blood Glucose Meters
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Continuous Glucose Monitoring Systems
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Flash Glucose Monitoring Systems
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.5. Smartphone Apps And Wearables
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
CHAPTER 5: GLUCOSE MONITORING DEVICES MARKET, BY PATIENT TYPE
5.1. Market Overview
5.1.1 Market Size and Forecast, By Patient Type
5.2. Type 1 Diabetes
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Type 2 Diabetes
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
CHAPTER 6: GLUCOSE MONITORING DEVICES MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Hospitals And Clinics
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Home Care Settings
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Others
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
CHAPTER 7: GLUCOSE MONITORING DEVICES MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Device
7.2.3. Market Size and Forecast, By Patient Type
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Glucose Monitoring Devices Market
7.2.6.1. Market Size and Forecast, By Device
7.2.6.2. Market Size and Forecast, By Patient Type
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Glucose Monitoring Devices Market
7.2.7.1. Market Size and Forecast, By Device
7.2.7.2. Market Size and Forecast, By Patient Type
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Glucose Monitoring Devices Market
7.2.8.1. Market Size and Forecast, By Device
7.2.8.2. Market Size and Forecast, By Patient Type
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Device
7.3.3. Market Size and Forecast, By Patient Type
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. France Glucose Monitoring Devices Market
7.3.6.1. Market Size and Forecast, By Device
7.3.6.2. Market Size and Forecast, By Patient Type
7.3.6.3. Market Size and Forecast, By End User
7.3.7. Germany Glucose Monitoring Devices Market
7.3.7.1. Market Size and Forecast, By Device
7.3.7.2. Market Size and Forecast, By Patient Type
7.3.7.3. Market Size and Forecast, By End User
7.3.8. Italy Glucose Monitoring Devices Market
7.3.8.1. Market Size and Forecast, By Device
7.3.8.2. Market Size and Forecast, By Patient Type
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Spain Glucose Monitoring Devices Market
7.3.9.1. Market Size and Forecast, By Device
7.3.9.2. Market Size and Forecast, By Patient Type
7.3.9.3. Market Size and Forecast, By End User
7.3.10. UK Glucose Monitoring Devices Market
7.3.10.1. Market Size and Forecast, By Device
7.3.10.2. Market Size and Forecast, By Patient Type
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest of Europe Glucose Monitoring Devices Market
7.3.11.1. Market Size and Forecast, By Device
7.3.11.2. Market Size and Forecast, By Patient Type
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Device
7.4.3. Market Size and Forecast, By Patient Type
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. China Glucose Monitoring Devices Market
7.4.6.1. Market Size and Forecast, By Device
7.4.6.2. Market Size and Forecast, By Patient Type
7.4.6.3. Market Size and Forecast, By End User
7.4.7. Japan Glucose Monitoring Devices Market
7.4.7.1. Market Size and Forecast, By Device
7.4.7.2. Market Size and Forecast, By Patient Type
7.4.7.3. Market Size and Forecast, By End User
7.4.8. India Glucose Monitoring Devices Market
7.4.8.1. Market Size and Forecast, By Device
7.4.8.2. Market Size and Forecast, By Patient Type
7.4.8.3. Market Size and Forecast, By End User
7.4.9. South Korea Glucose Monitoring Devices Market
7.4.9.1. Market Size and Forecast, By Device
7.4.9.2. Market Size and Forecast, By Patient Type
7.4.9.3. Market Size and Forecast, By End User
7.4.10. Australia Glucose Monitoring Devices Market
7.4.10.1. Market Size and Forecast, By Device
7.4.10.2. Market Size and Forecast, By Patient Type
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Glucose Monitoring Devices Market
7.4.11.1. Market Size and Forecast, By Device
7.4.11.2. Market Size and Forecast, By Patient Type
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Device
7.5.3. Market Size and Forecast, By Patient Type
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Glucose Monitoring Devices Market
7.5.6.1. Market Size and Forecast, By Device
7.5.6.2. Market Size and Forecast, By Patient Type
7.5.6.3. Market Size and Forecast, By End User
7.5.7. South Africa Glucose Monitoring Devices Market
7.5.7.1. Market Size and Forecast, By Device
7.5.7.2. Market Size and Forecast, By Patient Type
7.5.7.3. Market Size and Forecast, By End User
7.5.8. Saudi Arabia Glucose Monitoring Devices Market
7.5.8.1. Market Size and Forecast, By Device
7.5.8.2. Market Size and Forecast, By Patient Type
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Glucose Monitoring Devices Market
7.5.9.1. Market Size and Forecast, By Device
7.5.9.2. Market Size and Forecast, By Patient Type
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Menarini Diagnostics S.R.L.
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Senseonics, A.
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Novo Nordisk A/S
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. GlySens Incorporated
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Johnson And Johnson
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. DexCom, Inc.
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Medtronic Plc
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. F. Hoffman-La Roche Ltd
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Abbott Laboratories
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. B. Braun SE
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
